Literature DB >> 17659805

Delivery of drugs and macromolecules to mitochondria.

Abhijit Mukhopadhyay1, Henry Weiner.   

Abstract

Mitochondria is where the bulk of the cell's ATP is produced. Mutations occur to genes coding for members of the complexes involved in energy production. Some are a result of damages to nuclear coded genes and others to mitochondrial coded genes. This review describes approaches to bring small molecules, proteins and RNA/DNA into mitochondria. The purpose is to repair damaged genes as well as to interrupt mitochondrial function including energy production, oxygen radical formation and the apoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659805      PMCID: PMC2267434          DOI: 10.1016/j.addr.2007.06.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  90 in total

Review 1.  Mitochondria of protists.

Authors:  Michael W Gray; B Franz Lang; Gertraud Burger
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

Review 2.  Mitochondrial DNA mutations in human disease.

Authors:  Robert W Taylor; Doug M Turnbull
Journal:  Nat Rev Genet       Date:  2005-05       Impact factor: 53.242

Review 3.  Liposomes and liposome-like vesicles for drug and DNA delivery to mitochondria.

Authors:  Volkmar Weissig; Sarathi V Boddapati; Shing-Ming Cheng; Gerard G M D'Souza
Journal:  J Liposome Res       Date:  2006       Impact factor: 3.648

4.  POLG1 mutations associated with progressive encephalopathy in childhood.

Authors:  Gittan Kollberg; Ali-Reza Moslemi; Niklas Darin; Inger Nennesmo; Ingibjörg Bjarnadottir; Paul Uvebrant; Elisabeth Holme; Atle Melberg; Már Tulinius; Anders Oldfors
Journal:  J Neuropathol Exp Neurol       Date:  2006-08       Impact factor: 3.685

5.  Stable transformation of CHO Cells and human NARP cybrids confers oligomycin resistance (oli(r)) following transfer of a mitochondrial DNA-encoded oli(r) ATPase6 gene to the nuclear genome: a model system for mtDNA gene therapy.

Authors:  S J Zullo; W T Parks; M Chloupkova; B Wei; H Weiner; W A Fenton; J M Eisenstadt; C R Merril
Journal:  Rejuvenation Res       Date:  2005       Impact factor: 4.663

6.  Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria.

Authors:  Aleksandra Filipovska; Geoffrey F Kelso; Stephanie E Brown; Samantha M Beer; Robin A J Smith; Michael P Murphy
Journal:  J Biol Chem       Date:  2005-04-14       Impact factor: 5.157

7.  Processing of artificial peptide-DNA-conjugates by the mitochondrial intermediate peptidase (MIP).

Authors:  M Seibel; C Bachmann; J Schmiedel; N Wilken; F Wilde; H Reichmann; G Isaya; P Seibel; D Pfeiler
Journal:  Biol Chem       Date:  1999 Jul-Aug       Impact factor: 3.915

8.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours.

Authors:  Tilman Oltersdorf; Steven W Elmore; Alexander R Shoemaker; Robert C Armstrong; David J Augeri; Barbara A Belli; Milan Bruncko; Thomas L Deckwerth; Jurgen Dinges; Philip J Hajduk; Mary K Joseph; Shinichi Kitada; Stanley J Korsmeyer; Aaron R Kunzer; Anthony Letai; Chi Li; Michael J Mitten; David G Nettesheim; ShiChung Ng; Paul M Nimmer; Jacqueline M O'Connor; Anatol Oleksijew; Andrew M Petros; John C Reed; Wang Shen; Stephen K Tahir; Craig B Thompson; Kevin J Tomaselli; Baole Wang; Michael D Wendt; Haichao Zhang; Stephen W Fesik; Saul H Rosenberg
Journal:  Nature       Date:  2005-05-15       Impact factor: 49.962

9.  Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF.

Authors:  Takeshi Nagai; Akio Abe; Chihiro Sasakawa
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

10.  Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury.

Authors:  Victoria J Adlam; Joanne C Harrison; Carolyn M Porteous; Andrew M James; Robin A J Smith; Michael P Murphy; Ivan A Sammut
Journal:  FASEB J       Date:  2005-07       Impact factor: 5.191

View more
  16 in total

1.  Multiple triphenylphosphonium cations as a platform for the delivery of a pro-apoptotic peptide.

Authors:  Netanel Kolevzon; Uriel Kuflik; Miriam Shmuel; Sandrine Benhamron; Israel Ringel; Eylon Yavin
Journal:  Pharm Res       Date:  2011-06-02       Impact factor: 4.200

Review 2.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

3.  Active Targeting of the Nucleus Using Nonpeptidic Boronate Tags.

Authors:  Rui Tang; Ming Wang; Moumita Ray; Ying Jiang; Ziwen Jiang; Qiaobing Xu; Vincent M Rotello
Journal:  J Am Chem Soc       Date:  2017-06-19       Impact factor: 15.419

Review 4.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

5.  Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery.

Authors:  Yuma Yamada; Ryo Furukawa; Yukari Yasuzaki; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2011-06-21       Impact factor: 11.454

Review 6.  Mitochondrial dysfunction in retinal diseases.

Authors:  Megha Barot; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Curr Eye Res       Date:  2011-10-06       Impact factor: 2.424

7.  Toward intracellular targeted delivery of cancer therapeutics: progress and clinical outlook for brain tumor therapy.

Authors:  Hetal Pandya; Waldemar Debinski
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

8.  Mitochondrial delivery of doxorubicin by triphenylphosphonium-functionalized hyperbranched nanocarriers results in rapid and severe cytotoxicity.

Authors:  Theodossis A Theodossiou; Zili Sideratou; Maria E Katsarou; Dimitris Tsiourvas
Journal:  Pharm Res       Date:  2013-08-07       Impact factor: 4.200

9.  Nanoparticle Uptake: The Phagocyte Problem.

Authors:  Heather Herd Gustafson; Dolly Holt-Casper; David W Grainger; Hamidreza Ghandehari
Journal:  Nano Today       Date:  2015-09-05       Impact factor: 20.722

Review 10.  Receptor-targeted nanocarriers for therapeutic delivery to cancer.

Authors:  Bo Yu; Heng Chiat Tai; Weiming Xue; L James Lee; Robert J Lee
Journal:  Mol Membr Biol       Date:  2010-10       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.